The global Neurovascular Thrombectomy Device market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Stryker Corporation (U.S.)
Medtronic plc (Ireland)
Boston Scientific Corporation (U.S.)
Johnson & Johnson (U.S.)
Terumo Corporation (Japan)
Penumbra, Inc. (U.S.)
Spectranetics Corporation (U.S.)
Edwards Lifesciences Corporation (U.S.)
Argon Medical Devices, Inc. (U.S.)
Teleflex Incorporated (U.S.)
By Types:
Mechanical/Fragmentation Thrombectomy Devices
Stent Retrievers
Basket/Brush Retrievers
Coil Retrievers
Aspiration Thrombectomy Devices
Rheolytic/Hydrodynamic Thrombectomy Devices
Ultrasonic Thrombectomy Devices
By Applications:
Hospitals and Surgical Centers
Ambulatory Surgical Centers
Research Laboratories & Academic Institutes
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Neurovascular Thrombectomy Device Market Size Analysis from 2022 to 2027
1.5.1 Global Neurovascular Thrombectomy Device Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Neurovascular Thrombectomy Device Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Neurovascular Thrombectomy Device Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Neurovascular Thrombectomy Device Industry Impact
Chapter 2 Global Neurovascular Thrombectomy Device Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neurovascular Thrombectomy Device (Volume and Value) by Type
2.1.1 Global Neurovascular Thrombectomy Device Consumption and Market Share by Type (2016-2021)
2.1.2 Global Neurovascular Thrombectomy Device Revenue and Market Share by Type (2016-2021)
2.2 Global Neurovascular Thrombectomy Device (Volume and Value) by Application
2.2.1 Global Neurovascular Thrombectomy Device Consumption and Market Share by Application (2016-2021)
2.2.2 Global Neurovascular Thrombectomy Device Revenue and Market Share by Application (2016-2021)
2.3 Global Neurovascular Thrombectomy Device (Volume and Value) by Regions
2.3.1 Global Neurovascular Thrombectomy Device Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Neurovascular Thrombectomy Device Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Neurovascular Thrombectomy Device Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Neurovascular Thrombectomy Device Consumption by Regions (2016-2021)
4.2 North America Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
4.10 South America Neurovascular Thrombectomy Device Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Neurovascular Thrombectomy Device Market Analysis
5.1 North America Neurovascular Thrombectomy Device Consumption and Value Analysis
5.1.1 North America Neurovascular Thrombectomy Device Market Under COVID-19
5.2 North America Neurovascular Thrombectomy Device Consumption Volume by Types
5.3 North America Neurovascular Thrombectomy Device Consumption Structure by Application
5.4 North America Neurovascular Thrombectomy Device Consumption by Top Countries
5.4.1 United States Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
5.4.2 Canada Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
5.4.3 Mexico Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 6 East Asia Neurovascular Thrombectomy Device Market Analysis
6.1 East Asia Neurovascular Thrombectomy Device Consumption and Value Analysis
6.1.1 East Asia Neurovascular Thrombectomy Device Market Under COVID-19
6.2 East Asia Neurovascular Thrombectomy Device Consumption Volume by Types
6.3 East Asia Neurovascular Thrombectomy Device Consumption Structure by Application
6.4 East Asia Neurovascular Thrombectomy Device Consumption by Top Countries
6.4.1 China Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
6.4.2 Japan Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
6.4.3 South Korea Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 7 Europe Neurovascular Thrombectomy Device Market Analysis
7.1 Europe Neurovascular Thrombectomy Device Consumption and Value Analysis
7.1.1 Europe Neurovascular Thrombectomy Device Market Under COVID-19
7.2 Europe Neurovascular Thrombectomy Device Consumption Volume by Types
7.3 Europe Neurovascular Thrombectomy Device Consumption Structure by Application
7.4 Europe Neurovascular Thrombectomy Device Consumption by Top Countries
7.4.1 Germany Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.2 UK Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.3 France Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.4 Italy Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.5 Russia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.6 Spain Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.7 Netherlands Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.8 Switzerland Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
7.4.9 Poland Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 8 South Asia Neurovascular Thrombectomy Device Market Analysis
8.1 South Asia Neurovascular Thrombectomy Device Consumption and Value Analysis
8.1.1 South Asia Neurovascular Thrombectomy Device Market Under COVID-19
8.2 South Asia Neurovascular Thrombectomy Device Consumption Volume by Types
8.3 South Asia Neurovascular Thrombectomy Device Consumption Structure by Application
8.4 South Asia Neurovascular Thrombectomy Device Consumption by Top Countries
8.4.1 India Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
8.4.2 Pakistan Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Neurovascular Thrombectomy Device Market Analysis
9.1 Southeast Asia Neurovascular Thrombectomy Device Consumption and Value Analysis
9.1.1 Southeast Asia Neurovascular Thrombectomy Device Market Under COVID-19
9.2 Southeast Asia Neurovascular Thrombectomy Device Consumption Volume by Types
9.3 Southeast Asia Neurovascular Thrombectomy Device Consumption Structure by Application
9.4 Southeast Asia Neurovascular Thrombectomy Device Consumption by Top Countries
9.4.1 Indonesia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.2 Thailand Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.3 Singapore Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.4 Malaysia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.5 Philippines Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.6 Vietnam Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
9.4.7 Myanmar Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 10 Middle East Neurovascular Thrombectomy Device Market Analysis
10.1 Middle East Neurovascular Thrombectomy Device Consumption and Value Analysis
10.1.1 Middle East Neurovascular Thrombectomy Device Market Under COVID-19
10.2 Middle East Neurovascular Thrombectomy Device Consumption Volume by Types
10.3 Middle East Neurovascular Thrombectomy Device Consumption Structure by Application
10.4 Middle East Neurovascular Thrombectomy Device Consumption by Top Countries
10.4.1 Turkey Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.3 Iran Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.5 Israel Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.6 Iraq Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.7 Qatar Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.8 Kuwait Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
10.4.9 Oman Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 11 Africa Neurovascular Thrombectomy Device Market Analysis
11.1 Africa Neurovascular Thrombectomy Device Consumption and Value Analysis
11.1.1 Africa Neurovascular Thrombectomy Device Market Under COVID-19
11.2 Africa Neurovascular Thrombectomy Device Consumption Volume by Types
11.3 Africa Neurovascular Thrombectomy Device Consumption Structure by Application
11.4 Africa Neurovascular Thrombectomy Device Consumption by Top Countries
11.4.1 Nigeria Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
11.4.2 South Africa Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
11.4.3 Egypt Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
11.4.4 Algeria Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
11.4.5 Morocco Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 12 Oceania Neurovascular Thrombectomy Device Market Analysis
12.1 Oceania Neurovascular Thrombectomy Device Consumption and Value Analysis
12.2 Oceania Neurovascular Thrombectomy Device Consumption Volume by Types
12.3 Oceania Neurovascular Thrombectomy Device Consumption Structure by Application
12.4 Oceania Neurovascular Thrombectomy Device Consumption by Top Countries
12.4.1 Australia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
12.4.2 New Zealand Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 13 South America Neurovascular Thrombectomy Device Market Analysis
13.1 South America Neurovascular Thrombectomy Device Consumption and Value Analysis
13.1.1 South America Neurovascular Thrombectomy Device Market Under COVID-19
13.2 South America Neurovascular Thrombectomy Device Consumption Volume by Types
13.3 South America Neurovascular Thrombectomy Device Consumption Structure by Application
13.4 South America Neurovascular Thrombectomy Device Consumption Volume by Major Countries
13.4.1 Brazil Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.2 Argentina Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.3 Columbia Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.4 Chile Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.5 Venezuela Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.6 Peru Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
13.4.8 Ecuador Neurovascular Thrombectomy Device Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Neurovascular Thrombectomy Device Business
14.1 Stryker Corporation (U.S.)
14.1.1 Stryker Corporation (U.S.) Company Profile
14.1.2 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
14.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Medtronic plc (Ireland)
14.2.1 Medtronic plc (Ireland) Company Profile
14.2.2 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Specification
14.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Boston Scientific Corporation (U.S.)
14.3.1 Boston Scientific Corporation (U.S.) Company Profile
14.3.2 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
14.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Johnson & Johnson (U.S.)
14.4.1 Johnson & Johnson (U.S.) Company Profile
14.4.2 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product Specification
14.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Terumo Corporation (Japan)
14.5.1 Terumo Corporation (Japan) Company Profile
14.5.2 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Specification
14.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Penumbra, Inc. (U.S.)
14.6.1 Penumbra, Inc. (U.S.) Company Profile
14.6.2 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product Specification
14.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Spectranetics Corporation (U.S.)
14.7.1 Spectranetics Corporation (U.S.) Company Profile
14.7.2 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
14.7.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Edwards Lifesciences Corporation (U.S.)
14.8.1 Edwards Lifesciences Corporation (U.S.) Company Profile
14.8.2 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product Specification
14.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Argon Medical Devices, Inc. (U.S.)
14.9.1 Argon Medical Devices, Inc. (U.S.) Company Profile
14.9.2 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product Specification
14.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Teleflex Incorporated (U.S.)
14.10.1 Teleflex Incorporated (U.S.) Company Profile
14.10.2 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product Specification
14.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Neurovascular Thrombectomy Device Market Forecast (2022-2027)
15.1 Global Neurovascular Thrombectomy Device Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Neurovascular Thrombectomy Device Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Neurovascular Thrombectomy Device Value and Growth Rate Forecast (2022-2027)
15.2 Global Neurovascular Thrombectomy Device Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Neurovascular Thrombectomy Device Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Neurovascular Thrombectomy Device Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Neurovascular Thrombectomy Device Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Neurovascular Thrombectomy Device Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Neurovascular Thrombectomy Device Consumption Forecast by Type (2022-2027)
15.3.2 Global Neurovascular Thrombectomy Device Revenue Forecast by Type (2022-2027)
15.3.3 Global Neurovascular Thrombectomy Device Price Forecast by Type (2022-2027)
15.4 Global Neurovascular Thrombectomy Device Consumption Volume Forecast by Application (2022-2027)
15.5 Neurovascular Thrombectomy Device Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Price : US$ 3500 |
Date : Sep 2024 |
Category : Electronics |
Pages : 115 |
Price : US$ 3500 |
Date : Jul 2024 |
Category : Electronics |
Pages : 162 |